page_banner

news

Two Laurels witnessing innovative presence in Rehabilitation Field,Beoka has the honor to win the 25th Golden Bull Trophy

Two Laurels witnessing innovative presence in Rehabilitation Field,Beoka has the honor to win the 25th Golden Bull Trophy

On 23th, the ceremony themed ‚‘Advanced manufacturing and knowledge-intensive productivity——2023 Listed Companies High-quality Development Forum and the 25th Listed Companies Golden Bull Award Ceremony’ was successfully organized by China Securities Journal and Nantong Municipal People's Government。During the forum, More than 500 executives of listed companies, representatives of government departments and academician experts gathered together to discuss the high-quality development of listed companies in the new era.

Two1

The winners list of 8 awards of the 25th Golden Bull Award for Listed companies was announced at the forum. Among the many preeminent listed companies, starting from the views of medical and consumption, Beoka (stock code: 870199) ,by continuous self R&D and innovation to build own brand and realize brand internationalization strategy step by step, is high recognized and confirmed by the market. As a result, Beoka successfully won the "Golden Bull Little Giant Award" and also our chairman Wen Zhang honored to win "Golden Bull Innovation Entrepreneur Award"

Two2
Two3
Two4

2022 Golden Bull Little Giant Award

Two5
Two6

2022 Golden Bull Innovation Entrepreneur Award

Aimed to dig out the listed companies with excellence in sales, governance as well as high mission and social responsibility, since the founding of 1999,Since its inception in 1999, through a rigorous, objective, scientific and transparent selection system, the Golden Bull Award for Listed Companies aims to discover listed companies with excellent performance, excellent governance, lofty mission and social responsibility in the previous year, and build the most authoritative, professional and efficient communication and brand display platform in China's capital market. Nowadays, as one of the most credible and influential authoritative awards in China's capital market ,the award has become the beacon for leading listed companies to develop on the broad and bright track.

This award is an affirmation of the growth, standardization, innovation and development ability and long-term investment value of Bevy Health in the capital market. In the future development, Beoka will, as always, uphold the corporate mission of „Tech for Recovery • Care for life", take innovation as the drive, take quality as the core, and take service as the support, continue to deepen research and development and innovation, improve product quality, promote the healthy development of the industry, and create greater value for the society.


Post time: Nov-30-2023